In Vitro Lung Model Market Size To Reach $948.1 Million By 2030

In Vitro Lung Model Market Growth & Trends

The global in vitro lung model market size is expected to reach USD 948.1 million by 2030, growing at a CAGR of 17.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The factors driving market growth include increasing emphasis on creating substitutes for animal testing models, and recent global rise in respiratory-related disorders over the past few years. In vitro lung models help researchers replicate specific respiratory diseases, closely mimicking the cellular and molecular characteristics of these disorders for the development of potential treatment options. Thus, disease modeling contributes to the overall growth of in vitro lung models. Furthermore, as per The Humane Society of the United States (HSUS) report, about 50 million animals are used in experiments each year in the U.S. To mitigate cruelty to animals, the Animal Welfare Act (AWA) has established regulations aimed at reducing harmful experiments on animals.

Thus, over the past few years, there has been a notable global awareness and concern regarding the ethical treatment of animals in the research field. This emphasis has contributed to the increased demand for in vitro lung models worldwide. Furthermore, maintaining and testing on animals is expensive, whereas the use of in vitro models can be more cost-effective, especially for high-throughput screening of compounds and chemicals. This cost-effectiveness is appealing to researchers and organizations with limited budgets, making in vitro models a dependable alternative to animal testing. Key participants are adopting various strategies including partnerships, mergers & acquisitions, agreements, and product launches, to expand their global footprints and product portfolio. For instance, in June 2023, AlveoliX introduced a new organ-on-chip system that includes innovative 3D structure features, making mimicking any organ more convenient.

 Request a free sample copy or view report summary: In Vitro Lung Model Market Report

In Vitro Lung Model Market Report Highlights

• 2D model type dominated the market in 2023 due to their convenience, efficiency, and comprehensive nature

• The drug discovery & toxicology studies application segment dominated the market in 2023 as these models play a pivotal role in the early stages of pharmaceutical research & development

• Based on end-use, the pharmaceutical & biotechnology companies segment dominated the market in 2023 due to their critical role in drug development & research

• North America dominated the industry in 2023 owing to the presence of key players as well as academic research institutions in the region

• Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their market position

In Vitro Lung Model Market Segmentation

Grand View Research has segmented the global in vitro lung model market based on type, application, end-use, and region:

In Vitro Lung Model Type Outlook (Revenue, USD Million, 2018 - 2030)

• 2D Model

• 3D Model

In Vitro Lung Model Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Discovery & Toxicology Studies

• Physiological Research

• 3D Model Development

• Others

In Vitro Lung Model End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic Research Institutes

• Pharmaceutical & Biotechnology Companies

• Others

In Vitro Lung Model Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in In Vitro Lung Model Market

• Epithelix

• MATTEK

• Lonza

• Emulate

• AlveoliX AG

• Nortis

• CN Bio Innovations Ltd.

• MIMETAS

• InSphero

• ATTC Global